Department of Cardiovascular Diseases, University of Iowa Carver College of Medicine, Iowa City, Iowa 52242, USA.
JACC Cardiovasc Interv. 2013 Aug;6(8):814-23. doi: 10.1016/j.jcin.2013.04.010.
This study sought to determine the safety and efficacy of radial access compared with femoral access for primary percutaneous coronary intervention (PCI) in patients with ST-segment elevation myocardial infarction (STEMI).
Numerous randomized controlled trials, including several new studies, have compared outcomes of these approaches in the context of primary PCI for STEMI patients with inconclusive results.
We performed a meta-analysis of randomized controlled trials to compare outcomes in STEMI patients undergoing radial versus femoral access for primary PCI. Primary outcomes were death and major bleeding evaluated at the longest available follow-up. Secondary outcomes included access site bleeding, stroke, and procedure time. Twelve studies (N = 5,055) were included. All trials were conducted in centers experienced with both approaches.
Compared with femoral approach, radial approach was associated with decreased risk of mortality (2.7% vs. 4.7%; odds ratio [OR]: 0.55, 95% confidence interval [CI]: 0.40 to 0.76; p < 0.001) and decreased risk of major bleeding (1.4% vs. 2.9%; OR: 0.51, 95% CI: 0.31 to 0.85; p = 0.01). Radial access was also associated with reduction in relative risk of access site bleeding (2.1% vs. 5.6%; OR: 0.35, 95% CI: 0.25 to 0.50; p < 0.001). Stroke risk was similar between both approaches (0.5% vs. 0.5%; OR: 1.07, 95% CI: 0.45 to 2.54; p = 0.87). The procedure time was slightly longer in the radial group than in the femoral group (mean difference: 1.52 min; 95% CI: 0.33 to 2.70, p = 0.01).
In STEMI patients undergoing primary PCI, the radial approach is associated with favorable outcomes and should be the preferred approach for experienced radial operators.
本研究旨在确定与股动脉入路相比,桡动脉入路用于 ST 段抬高型心肌梗死(STEMI)患者直接经皮冠状动脉介入治疗(PCI)的安全性和有效性。
包括几项新研究在内的大量随机对照试验对这些方法在 STEMI 患者直接 PCI 中的应用结果进行了比较,但结果尚无定论。
我们对比较直接 PCI 中桡动脉与股动脉入路用于 STEMI 患者的随机对照试验进行了荟萃分析。主要终点为最长随访期内的死亡和主要出血。次要终点包括穿刺部位出血、卒中和手术时间。共纳入 12 项研究(n=5055)。所有试验均在具有这两种入路经验的中心进行。
与股动脉入路相比,桡动脉入路与死亡率降低相关(2.7%比 4.7%;比值比[OR]:0.55,95%置信区间[CI]:0.40 至 0.76;p<0.001),主要出血风险降低(1.4%比 2.9%;OR:0.51,95% CI:0.31 至 0.85;p=0.01)。桡动脉入路还与穿刺部位出血的相对风险降低相关(2.1%比 5.6%;OR:0.35,95% CI:0.25 至 0.50;p<0.001)。两种方法的卒中风险相似(0.5%比 0.5%;OR:1.07,95% CI:0.45 至 2.54;p=0.87)。桡动脉组的手术时间略长于股动脉组(平均差值:1.52 分钟;95% CI:0.33 至 2.70,p=0.01)。
在 STEMI 患者直接 PCI 中,桡动脉入路具有良好的结果,应成为经验丰富的桡动脉操作者的首选方法。